Tempus CEO Eric Lefkofsky discusses the company’s artificial intelligence-driven precision medicine partnership with Merck on ‘The Claman Countdown.’
Tempus founder and CEO Eric Lefkofsky discusses how the company is using artificial intelligence and large-scale clinical data to help determine which treatments patients may need. Lefkofsky also explains how Tempus’ partnership with Merck could advance precision medicine and potentially reduce healthcare costs on ‘The Claman Countdown.’
Read the full article here